Ziqiang Q. Tian

No. 169 Tianshan Street
Shijiazhuang, 050035, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 71 publications

Surgery-based treatment and prognostic factors in patients with limited-stage small cell lung cancer: a retrospective cohort study.

Surgery-based treatment and prognostic factors in patients with limited-stage small cell lung cancer: a retrospective cohort study.

Journal: Frontiers in oncology

Published: February 10, 2026

Survival Differences Among Non-pCR Patients with Distinct Pathological Outcomes After Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma.

Survival Differences Among Non-pCR Patients with Distinct Pathological Outcomes After Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma.

Journal: The Journal of thoracic and cardiovascular surgery

Published: January 22, 2026

Survival differences among patients with nonpathological complete response with distinct pathological outcomes after neoadjuvant therapy for esophageal squamous cell carcinoma.

Survival differences among patients with nonpathological complete response with distinct pathological outcomes after neoadjuvant therapy for esophageal squamous cell carcinoma.

Journal: The Journal of thoracic and cardiovascular surgery

Published: January 22, 2026

Long non-coding RNA LINC00092 inhibits esophageal squamous cell carcinoma progression by promoting ferroptosis through the MAZ/NFE2L2 axis.

Long non-coding RNA LINC00092 inhibits esophageal squamous cell carcinoma progression by promoting ferroptosis through the MAZ/NFE2L2 axis.

Journal: Journal of thoracic disease

Published: November 21, 2025

[18F]FDG PET/CT versus pelvic MRI in preoperative diagnosis of lateral lymph node metastasis in rectal cancer: a meta-analysis.

[18F]FDG PET/CT versus pelvic MRI in preoperative diagnosis of lateral lymph node metastasis in rectal cancer: a meta-analysis.

Journal: Clinical radiology

Published: November 05, 2025

Association of immune-related adverse events with survival outcomes in esophageal squamous cell carcinoma following neoadjuvant chemoimmunotherapy: a national multicenter retrospective cohort study in China.

Association of immune-related adverse events with survival outcomes in esophageal squamous cell carcinoma following neoadjuvant chemoimmunotherapy: a national multicenter retrospective cohort study in China.

Journal: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus

Published: November 04, 2025

Pathologic complete response after neoadjuvant immunochemotherapy: Persistent recurrence risk highlights the need for stratified management.

Pathologic complete response after neoadjuvant immunochemotherapy: Persistent recurrence risk highlights the need for stratified management.

Journal: The Journal of thoracic and cardiovascular surgery

Published: November 04, 2025

Efficacy and safety of immunotherapy combined with chemotherapy as conversion therapy for initially unresectable locally advanced esophageal squamous cell carcinoma

Efficacy and safety of immunotherapy combined with chemotherapy as conversion therapy for initially unresectable locally advanced esophageal squamous cell carcinoma

Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]

Published: September 27, 2025

Efficacy and safety of secondary induction radiotherapy in locally advanced resectable esophageal squamous cell carcinoma with poor responses to neoadjuvant immunochemotherapy: a retrospective study.

Efficacy and safety of secondary induction radiotherapy in locally advanced resectable esophageal squamous cell carcinoma with poor responses to neoadjuvant immunochemotherapy: a retrospective study.

Journal: Frontiers in immunology

Published: June 30, 2025

Adjuvant immunotherapy for esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapy: a multicenter real-world study.

Adjuvant immunotherapy for esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapy: a multicenter real-world study.

Journal: International journal of surgery (London, England)

Published: June 23, 2025

Efficacy and survival analysis of neoadjuvant chemotherapy combined with immunotherapy in locally advanced resectable Siewert type II adenocarcinoma of the esophagogastric junction.

Efficacy and survival analysis of neoadjuvant chemotherapy combined with immunotherapy in locally advanced resectable Siewert type II adenocarcinoma of the esophagogastric junction.

Journal: Frontiers in oncology

Published: June 07, 2025

Strategies of neoadjuvant therapy in esophageal cancer: a study on the effects of treatment frequency and surgery interval.

Strategies of neoadjuvant therapy in esophageal cancer: a study on the effects of treatment frequency and surgery interval.

Journal: Frontiers in oncology

Published: June 07, 2025

Showing 1-12 of 71

Last Updated: 09/26/2026